EUCTR2019-001724-35-ES进行中（未招募）1 期
AMASCIS-02. ALOGENIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS IN ISCHEMIC STROKE. A PHASE IIB MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL.
Fundación para la Investigación Biomédica del Hospital Universitario de La Paz (FIBHULP)0 个研究点目标入组 30 人开始时间: 2022年7月11日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male and female acute ischemic patients aged more than 18 years
- •2. Patients should be treated within 4 days (+/-1 days) from the onset of stroke symptoms. If the time of symptom onset is unknown, this shall refer to the last time the patient was observed as asymptomatic.
- •3. A computed tomography (CT) or magnetic resonance imaging (MRI) scan compatible with the clinical diagnosis of acute non-lacunar IS in the region of the middle cerebral artery (with cortical or subcortical involvement).
- •4 .A score on the National Institute of Health Stroke Scale (NIHSS) of 8-20, with at least two of these points in sections 5 and 6 (motor deficit) at the time of inclusion and in which a measurable focal neurologic deficit persists to the time of treatment.
- •5. A prestroke score on the Modified Rankin Scale (mRS) =1 (no significant disability).
- •6. Female subjects non-child bearing potential. Female subjects who are of non-childbearing potential are defined as meeting at least 1 of the following criteria:
- •a)Have undergone a documented hysterectomy and/or bilateral oophorectomy;
- •b)Have medically confirmed ovarian failure; or
- •c)Achieved postmenopausal status, defined as follows: cessation of regular menses for at least 12 consecutive months with no alternative pathological or physiological cause.
- •7. Female subjects of child-bearing potential need a negative pregnancy test and must agree to use adequate contraception for the duration of the study (from screening through the final of the study). The following types of contraception are considered adequate provided they are locally authorized for use: oral, transdermal, or injectable (depot) estrogen and/or progestogen, selective estrogen receptor modulator therapy, intrauterine contraceptive device, double barrier method (e.g., condom and diaphragm or spermicidal gel) or vasectomy.
- •8. Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •1. Comatose patients; patients with a score of 2 or more on item 1a of the NIHSS related to the degree of awareness.
- •2. Evidence on neuroimaging of a brain tumor, cerebral edema with midline shift and a clinically significant compression of ventricles, cerebellar or brainstem infarction, and intraventricular, intracerebral, or subarachnoid hemorrhage. Petechial small haemorrhages are not exclusion criteria.
- •3. Current drug or alcohol use or dependence.
- •4. Active infectious disease, including human immunodeficiency virus, hepatitis B, and hepatitis C. A controlled infection is not an exclusion criterion.
- •5. Pre-existing dementia.
- •6. A health status, any clinical condition (eg, short life expectancy, and coexisting disease or a surgical or endovascular planned procedure) or other characteristic that precludes appropriate diagnosis, treatment, or follow-up in the trial.
- •7. Patients who are participating in another clinical trial.
- •8. Inability or unwillingness of the individual or their legal guardian/representative to provide written informed consent.
研究者
相似试验
进行中（未招募）
1 期
CLINICAL TRIAL WITH MESENCHYMAL STEM CELLS IN STROKE PATIENTSCTIS2024-512514-18-00Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz30
已完成
不适用
Effect of Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection in Rotator Cuff DiseaseDiseases of the musculo-skeletal system and connective tissueKCT0001523Seoul Metropolitan Government Seoul National University Boramae Medical Center18
招募中
1 期
The effect of fat-derived stem cells in treatment of multiple sclerosismultiple sclerosis.Demyelinating diseases of the central nervous system, multiple sclerosisG35-G37IRCT20091127002778N1Mashhad University of Medical Sciences10
终止
2 期
Evaluation of mesenchymal stem cells in the treatment of knee osteoarthritis – prospective case series data collectioOsteoarthritisACTRN12615000258550Magellan Stem Cells100
终止
2 期
Evaluation of mesenchymal stem cells in the treatment of hip osteoarthritis – prospective case series data collectioOsteoarthritisACTRN12615000260527Magellan Stem Cells100